135 related articles for article (PubMed ID: 12472520)
1. p53 Expression and keratinocyte hyperproliferation in middle ear cholesteatoma.
Motamed M; Powe D; Kendall C; Birchall JP; Banerjee AR
Clin Otolaryngol Allied Sci; 2002 Dec; 27(6):505-8. PubMed ID: 12472520
[TBL] [Abstract][Full Text] [Related]
2. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
[TBL] [Abstract][Full Text] [Related]
3. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.
Sudhoff H; Bujía J; Fisseler-Eckhoff A; Holly A; Schulz-Flake C; Hildmann H
Laryngoscope; 1995 Nov; 105(11):1227-31. PubMed ID: 7475881
[TBL] [Abstract][Full Text] [Related]
4. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
Shinoda H; Huang CC
Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
[TBL] [Abstract][Full Text] [Related]
5. [The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].
Zhu Z; Hong Y; Wang Y; He G; Ye S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 30(2):139-43. PubMed ID: 27192911
[TBL] [Abstract][Full Text] [Related]
6. Are p53 and MIB-1 overexpressed in cholesteatoma?
Motamed M; Powe D; Jones L; Kendall C; Banerjee AR
Clin Otolaryngol Allied Sci; 2000 Dec; 25(6):570-6. PubMed ID: 11122306
[TBL] [Abstract][Full Text] [Related]
7. [Role of epithelial cell proliferation and apoptosis in human middle ear cholesteatoma].
Zhu W; Huang D; Jing L; Zhang F
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Jul; 15(7):291-2, 295. PubMed ID: 12541781
[TBL] [Abstract][Full Text] [Related]
8. Expression of Apoptotic vs Antiapoptotic Proteins in Middle Ear Cholesteatoma.
Chung JH; Lee SH; Park CW; Kim KR; Tae K; Kang SH; Oh YH; Pyo JY
Otolaryngol Head Neck Surg; 2015 Dec; 153(6):1024-30. PubMed ID: 26124267
[TBL] [Abstract][Full Text] [Related]
9. [Comparative analysis of the proliferative capacity of cholesteatomas].
Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
[TBL] [Abstract][Full Text] [Related]
10. Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1.
Bujía J; Holly A; Antolí-Candela F; Tapia MG; Kastenbauer E
Laryngoscope; 1996 Jul; 106(7):865-8. PubMed ID: 8667984
[TBL] [Abstract][Full Text] [Related]
11. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis.
Huisman MA; De Heer E; Grote JJ
Acta Otolaryngol; 2003 Apr; 123(3):377-82. PubMed ID: 12737294
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical investigations on external auditory canal cholesteatomas.
Adamczyk M; Sudhoff H; Jahnke K
Otol Neurotol; 2003 Sep; 24(5):705-8. PubMed ID: 14501442
[TBL] [Abstract][Full Text] [Related]
13. Heat shock proteins in middle ear cholesteatoma.
Shinoda H; Huang CC
Otolaryngol Head Neck Surg; 1996 Jan; 114(1):77-83. PubMed ID: 8570255
[TBL] [Abstract][Full Text] [Related]
14. Argyrophilic nucleolar organizer regions in auditory meatal skin and middle ear cholesteatoma.
Sudhoff H; Fisseler-Eckhoff A; Stark T; Borkowski G; Luckhaupt H; Cooper J; Michaels L
Clin Otolaryngol Allied Sci; 1997 Dec; 22(6):545-8. PubMed ID: 9466068
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications.
Albino AP; Reed JA; Bogdany JK; Sassoon J; Desloge RB; Parisier SC
Am J Otol; 1998 Jan; 19(1):30-6. PubMed ID: 9455944
[TBL] [Abstract][Full Text] [Related]
16. The oncoprotein, gankyrin, is up-regulated in middle ear cholesteatoma.
Kim KH; Lim HJ; Kim YJ; Kim SW; Kim YS; Tian C; Park K; Park TJ; Choung YH
Acta Otolaryngol; 2014 Mar; 134(3):238-43. PubMed ID: 24460153
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical studies with middle ear mucosal remnants in cholesteatoma].
Sudhoff H; Borkowski G; Bujia J; Hildmann H; Fisseler-Eckhoff A
HNO; 1997 Aug; 45(8):630-5. PubMed ID: 9378670
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
[TBL] [Abstract][Full Text] [Related]
19. Sustained extracellular signal-regulated kinase1/2 mitogen-activated protein kinase signalling is related to increased p21 expression in cholesteatoma epithelium.
Huisman MA; De Heer E; Grote JJ
Acta Otolaryngol; 2005 Feb; 125(2):134-40. PubMed ID: 15880942
[TBL] [Abstract][Full Text] [Related]
20. [Expression of calgranulin A and B in middle ear cholesteatoma].
Holly A; Bujía J; Lempart K; Serge M
Laryngorhinootologie; 1995 Jan; 74(1):33-5. PubMed ID: 7888019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
